NanoLogix Inc. Presents at the National Hydrogen Association Conference &
Provides Operations, Management and Director Update
HUBBARD, Ohio, March 31 /PRNewswire-FirstCall/ -- NanoLogix, Inc.
(OTC: NNLX - News) a nano-biotechnology company is pleased to provide the
following updates on company events:
NanoLogix personnel are manning a booth and presenting at the National Hydrogen
Association Expo in Sacramento this week, with the company being represented by
William Hartman and Chris Novak. Mr. Hartman will be presenting in the Exhibition Hall
today, March 31, from 2:00-2:30 pm, on "Biohydrogen and Electricity Production from Waste Water".
Company CEO Bret Barnhizer was Marlene Bourne's guest on The Bourne
Report March 16, on the topic of Hydrogen Power. The interview provides updates
on hydrogen bioreactor operations. Access:
http://www.bournereport.com/radio.php
Work on BNC and BNP development for fast microorganism detection is proceeding at
a rapid pace, with a new patent application filed in March and positive developments
with both the Departments of Defense and Homeland Security in late February.
Director and Management changes: Dr. Robert Ollar and John Chatterton have
joined the Board of Directors. Dr. Ollar is cofounder of NanoLogix (as Infectech),
the primary author of the majority of the company's granted patents, and returns to
the company after a six year hiatus. Mr. Chatterton is former co-host of the History
Channel series, Deep Sea Detectives, and is one of the world's most accomplished and
well known underwater explorers. David Barnhizer has joined the company as General Counsel,
bringing to the company nearly forty years of legal expertise. Detailed director and
management team information can be accessed at:
http://www.nanologixinc.com/index-2.html
General Counsel David Barnhizer stated: "NNLX is poised to make a significant
move forward under its new board of directors and management team headed by CEO
and Board Chairman Bret Barnhizer and complemented by a reformed and greatly
strengthened board of directors. A skilled and knowledgeable team of professionals
whose members are fully dedicated to the advancement of NanoLogix has been put into
place. As NNLX General Counsel I am extremely pleased to be associated with a group
of professionals committed to the building of an exceptional company whose patented
technologies are on the cutting edge of hydrogen energy extraction from industrial
and commercial wastes, as well as diagnostic tools that are drawing the attention of
governmental and commercial institutions."
The company has accepted the resignations of directors Hartman, Allan,
and Cavallo from all positions held. Mr. Hartman will continue to provide business
consulting services to NanoLogix.
About NanoLogix, Inc.
NanoLogix is a leading innovator in the research, development, and commercialization
of nano-biotechnologies, applications and processes. The Company has 31 granted Patents
and multiple Patents Pending for bioreactor- based Hydrogen Production, revolutionary rapid
medical testing technologies, and bioremediation. Information on NanoLogix is available at
www.nanologixinc.com.
This press release contains statements, which may constitute
"forward- looking statements" within the meaning of the Securities Act of 1933 and the
Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform
Act of 1995. Those statements include statements regarding the intent, belief or current
expectations of NanoLogix, Inc., and members of its management as well as the assumptions
on which such statements are based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from those contemplated by such
forward-looking statements. The Company undertakes no obligation to update or revise
forward-looking statements to reflect changed assumptions, the occurrence of unanticipated
events or changes to future operating results.
________________________________________
Contact:
NanoLogix, Inc.
Investor Relations
Bret Barnhizer, CEO
Telephone: 330-534-0800
E-mail:
Bret@nanologixinc.com
